Increased serum K levels w/ succinylcholine. Ventricular arrhythmia w/ β-sympathomimetic agents eg, isoprenaline, α- & β-sympathomimetic agents eg, adrenaline & noradrenaline. Risk of crisis w/ non-selective MAOIs. Increased plasma fluoride conc w/ INH, alcohol. Increased risk of potentiated hepatotoxic effects w/ INH. Marked hypotension w/ Ca antagonists eg, dihydropyridine derivatives. Risk of additive -ve inotropic effect w/ inhalation anaesths. Resp depression w/ opioids, benzodiazepines & other sedative agents.